CytoMed Therapeutics
GDTC
#10143
Rank
NZ$37.64 M
Marketcap
NZ$3.21
Share price
5.71%
Change (1 day)
-40.91%
Change (1 year)

Revenue for CytoMed Therapeutics (GDTC)

Revenue in 2024: NZ$0.08 Million

According to CytoMed Therapeutics's latest financial reports the company's current revenue (TTM ) is NZ$0.08 Million. In 2024 the company made a revenue of NZ$0.08 Million an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for CytoMed Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024NZ$0.08 M
2023N/A
2022N/A
2021N/A
2020N/A